OBJECTIVE: Successful implantation and placentation depend on the interaction between the endometrium and the embryo. Angiogenesis is crucial at this time. In this article we investigate the direct influence of the human embryo on in vitro endometrial angiogenesis. DESIGN: In vitro study. SETTING: Human endometrial microvascular endothelial cells (hEMVEC) grown on an in vitro angiogenesis model. INTERVENTION(S): Conditioned media (CM) of human embryos were used to stimulate in vitro angiogenesis. MAIN OUTCOME MEASURE(S): In vitro angiogenesis of hEMVEC. RESULT(S): Conditioned media of human embryos, containing significant amounts of vascular endothelial growth factor (VEGF)-A, as determined by enzyme-linked immunosorbent assay (ELISA), caused an increase in hEMVEC tube formation. This effect was prevented by soluble VEGF receptor 1, which quenches VEGF-A activity. Recombinant EGF alone and leukemia inhibitory factor in combination with VEGF-A stimulated hEMVEC tube formation. None of the other tested recombinant mediators, which have been described as produced by the early embryo/trophoblast (interleukin (IL) 10, transforming growth factor (TGF) beta, placental growth factor, hCG, colony-stimulating factor 1, interferon-gamma, insulin-like growth factor I and II, IL-6, platelet-derived growth factor, and TGFalpha), had an effect on tube formation by hEMVEC. CONCLUSION(S): For the first time, it is shown that the human embryo is able to stimulate in vitro endometrial angiogenesis at the time of implantation, a process that is mediated by VEGF-A.
OBJECTIVE: Successful implantation and placentation depend on the interaction between the endometrium and the embryo. Angiogenesis is crucial at this time. In this article we investigate the direct influence of the human embryo on in vitro endometrial angiogenesis. DESIGN: In vitro study. SETTING:Human endometrial microvascular endothelial cells (hEMVEC) grown on an in vitro angiogenesis model. INTERVENTION(S): Conditioned media (CM) of human embryos were used to stimulate in vitro angiogenesis. MAIN OUTCOME MEASURE(S): In vitro angiogenesis of hEMVEC. RESULT(S): Conditioned media of human embryos, containing significant amounts of vascular endothelial growth factor (VEGF)-A, as determined by enzyme-linked immunosorbent assay (ELISA), caused an increase in hEMVEC tube formation. This effect was prevented by soluble VEGF receptor 1, which quenches VEGF-A activity. Recombinant EGF alone and leukemia inhibitory factor in combination with VEGF-A stimulated hEMVEC tube formation. None of the other tested recombinant mediators, which have been described as produced by the early embryo/trophoblast (interleukin (IL) 10, transforming growth factor (TGF) beta, placental growth factor, hCG, colony-stimulating factor 1, interferon-gamma, insulin-like growth factor I and II, IL-6, platelet-derived growth factor, and TGFalpha), had an effect on tube formation by hEMVEC. CONCLUSION(S): For the first time, it is shown that the human embryo is able to stimulate in vitro endometrial angiogenesis at the time of implantation, a process that is mediated by VEGF-A.
Authors: Uros Midic; Benjamin Goheen; Kailey A Vincent; Catherine A VandeVoort; Keith E Latham Journal: Reprod Toxicol Date: 2018-03-02 Impact factor: 3.143
Authors: Jelena Krstic; Alexander Deutsch; Julia Fuchs; Martin Gauster; Tina Gorsek Sparovec; Ursula Hiden; Julian Christopher Krappinger; Gerit Moser; Katrin Pansy; Marta Szmyra; Daniela Gold; Julia Feichtinger; Berthold Huppertz Journal: Biomedicines Date: 2022-05-04
Authors: Radia Boudjenah; Denise Molina-Gomes; Robert Wainer; Philippe de Mazancourt; Jacqueline Selva; François Vialard Journal: J Assist Reprod Genet Date: 2012-10-27 Impact factor: 3.412
Authors: Jessica R Zolton; Lindsey A Sjaarda; Sunni L Mumford; Elizabeth A DeVilbiss; Keewan Kim; Kerry S Flannagan; Jeannie G Radoc; Neil J Perkins; Robert M Silver; Jean Wactawski-Wende; Micah J Hill; Alan H DeCherney; Enrique F Schisterman Journal: Obstet Gynecol Date: 2021-01-01 Impact factor: 7.623
Authors: Laura D Vagnini; Adriana M Nascimento; Maria do Carmo T Canas; Adriana Renzi; Gabriela R Oliveira-Pelegrin; Claudia G Petersen; Ana L Mauri; João Batista A Oliveira; Ricardo L R Baruffi; Mario Cavagna; José G Franco Journal: Med Princ Pract Date: 2015-08-21 Impact factor: 1.927